Literature DB >> 1854659

Terminology of torsades de pointes.

D Tzivoni1, A Keren, S Banai, S Stern.   

Abstract

Marked prolongation of the QT interval may be associated with life-threatening ventricular tachycardia. The ventricular tachycardia has a polymorphous appearance and is usually induced by antiarrhythmic drugs. This peculiar type of ventricular tachycardia was termed by Desserstenne torsades de pointes because of its twisting ORS axis. The main reason to give this entity a special name that differentiates it from other types of ventricular tachycardia is the unique therapeutic approach to its treatment. Torsades de pointes can be suppressed by interventions that shorten the QT interval by increasing the heart rate, such as ventricular or atrial pacing, isoproterenol infusion, or atropine. Recently intravenous magnesium was also shown to be extremely effective. If torsades de pointes is treated as a conventional ventricular tachycardia by drugs that may further prolong the QT interval, it may lead to fatal results. To draw the attention of physicians to this unusual form of ventricular tachycardia, we suggest that the term torsades de pointes be kept. This specific diagnosis will hopefully guide the treating physician in selecting the appropriate mode of therapy.

Entities:  

Mesh:

Year:  1991        PMID: 1854659     DOI: 10.1007/bf03029777

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  15 in total

1.  QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

Authors:  A SELZER; H W WRAY
Journal:  Circulation       Date:  1964-07       Impact factor: 29.690

2.  Torsade De Pointes, an atypical ventricular tachycardia.

Authors:  D M Krikler; P V Curry
Journal:  Br Heart J       Date:  1976-02

3.  Treatment of torsade de pointes with magnesium sulfate.

Authors:  D Tzivoni; S Banai; C Schuger; J Benhorin; A Keren; S Gottlieb; S Stern
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

4.  [Ventricular tachycardia with 2 variable opposing foci].

Authors:  F Dessertenne
Journal:  Arch Mal Coeur Vaiss       Date:  1966-02

5.  Successful treatment by overdrive pacing of recurrent quinidine syncope due to ventricular tachycardia.

Authors:  J L Anderson; J W Mason
Journal:  Am J Med       Date:  1978-04       Impact factor: 4.965

6.  Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs.

Authors:  D S Bailie; H Inoue; S Kaseda; J Ben-David; D P Zipes
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

7.  Nonsustained polymorphic ventricular tachycardia induced by electrical stimulation in 3 week old canine myocardial infarction.

Authors:  H Garan; J T Fallon; J N Ruskin
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

8.  Polymorphous ventricular tachycardia: clinical features and treatment.

Authors:  S Sclarovksy; B Strasberg; R F Lewin; J Agmon
Journal:  Am J Cardiol       Date:  1979-08       Impact factor: 2.778

9.  Disopyramide-induced Torsade de Pointes.

Authors:  D Tzivoni; A Keren; S Stern; S Gottlieb
Journal:  Arch Intern Med       Date:  1981-06

10.  Procainamide-induced polymorphous ventricular tachycardia.

Authors:  B Strasberg; S Sclarovsky; A Erdberg; C E Duffy; W Lam; S Swiryn; J Agmon; K M Rosen
Journal:  Am J Cardiol       Date:  1981-06       Impact factor: 2.778

View more
  1 in total

Review 1.  Drugs, QT interval prolongation and ICH E14: the need to get it right.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.